Physician

Tara Oetken, M.D.

According to 2025 Medicare claims, Tara Oetken, M.D. (NPI: 1982067450) practices dermatology in the Bozeman, MT market, with the plurality of this provider's patient population coming from Gallatin, MT. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1710869730) and primary practice location at 59718-4061. Oetken is affiliated with the MultiCare Connected Care, LLC (ACO ID: A3631) and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Oetken's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,015 traditional Medicare patients, billed 5,237 HCPCS/CPT codes, and received $261,149 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 881 prescription claims across 378 beneficiaries totaling $739,603 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 71 records totaling $1,782. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $5,343 to $739,603. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$162K$324K2020 Medicare payment: $90,681 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $241,796 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $199,996 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $323,655 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $261,149 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20204922,065$90,681
20218964,758$241,796
20227514,038$199,996
20239236,119$323,655
20241,0155,237$261,149

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$459K$918K2016 Drug cost: $5,343 (USD; Tot_Drug_Cst)2017 Drug cost: $36,817 (USD; Tot_Drug_Cst)2018 Drug cost: $261,537 (USD; Tot_Drug_Cst)2019 Drug cost: $142,104 (USD; Tot_Drug_Cst)2020 Drug cost: $157,958 (USD; Tot_Drug_Cst)2021 Drug cost: $354,086 (USD; Tot_Drug_Cst)2022 Drug cost: $385,190 (USD; Tot_Drug_Cst)2023 Drug cost: $917,706 (USD; Tot_Drug_Cst)2024 Drug cost: $739,603 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161951$5,343
201765154$36,817
2018130372$261,537
201985270$142,104
2020129315$157,958
2021255581$354,086
2022257641$385,190
2023347956$917,706
2024378881$739,603

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more323395$83
11102Biopsy of related skin growth, first growth372404$60
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more543603$55
17000Destruction of precancer skin growth, 1 growth463539$34
17003Destruction of precancer skin growth, 2-14 growths3351,771$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab18504$265,148
OtezlaApremilast29870$148,605
Taltz AutoinjectorIxekizumab16462$110,375
Dupixent PenDupilumab19532$77,780
Clobetasol PropionateClobetasol Propionate1333,796$4,558

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.71$1,782ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Tara Oetken, M.D.?

Tedicare shows public-source Medicare data for Tara Oetken, M.D. (NPI 1982067450), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tara Oetken, M.D. have ACO affiliation data?

Tara Oetken, M.D. is shown with ACO affiliation data for MultiCare Connected Care, LLC (MSSP, ACO ID A3631) and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Tara Oetken, M.D.?

Tara Oetken, M.D. is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1710869730) in the available physician profile data.

Does Tara Oetken, M.D. have Open Payments data?

Tara Oetken, M.D. has 71 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.